Executive Summary
peptide 2008. A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.Peptides, 29(4): 529–535. DOI: 10.1016/j.peptides.2008.01.004. Chen
The scientific literature of 2008 presented significant advancements in the understanding and application of peptides. Among these, the publication in *Peptides*, Volume 29, Issue 4, pages 529-535, detailing a novel antimicrobial peptide, stands out. This research, authored by Chen and colleagues, focused on exocrine secretions from venomous and toxic organisms, specifically identifying an antimicrobial peptide from the skin secretions of *Odorrana grahami*, an amphibian. This particular publication, often referenced by its journal, volume, issue, and page numbers ( Peptides, 29(4): 529–535), represents a notable contribution to the field of peptide research.
The study's core finding was the isolation and characterization of a novel antimicrobial peptide. This peptide demonstrated potent activity, suggesting its potential as a therapeutic agent against various microbial threats. The research delved into the molecular mechanisms by which this peptide exerts its antimicrobial effects, a crucial aspect for developing new drugs and understanding biological processes. The identification of such peptide analogues is vital, as they can be further modified to enhance their efficacy or stability.
Beyond this specific publication, the broader scientific community in 2008 was actively exploring the diverse roles of peptides. For instance, research by Purcell and colleagues investigated the "Molecular machinations of the MHC-I peptide loading" process, highlighting the critical role of peptide ligands in the generation of immunity against viruses and tumors. This work underscores the importance of peptide interactions in the immune system.
Another significant area of peptide research in 2008, as indicated by Miranda and collaborators, involved the "Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor." This research has implications for understanding and treating conditions related to CGRP signaling, such as migraines and other neurological disorders. The pursuit of metabolically stable peptides is a common theme in drug development, aiming to increase their longevity and effectiveness within the body.
Furthermore, the synthesis and production of peptides were also under investigation. A study by Sottile dating back to 1987, but relevant to the ongoing exploration of peptide biology, focused on the "Enhanced synthesis of a Mr = 55000 dalton peptide." This earlier work demonstrated that late-passage cell cultures could synthesize this specific peptide irrespective of fetal bovine serum, providing insights into cellular peptide production mechanisms.
The general interest in what are peptides extends to their applications in various fields, including skincare. Brands like Clinique offer products that incorporate peptides, touting their potential benefits for skin health and anti-aging. This broader public interest signifies the growing recognition of peptides beyond their fundamental biological roles.
The exploration of peptide analogues also extends to their potential to alter disease progression. Research from 1993 by Liebow demonstrated that peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence. This highlights the therapeutic potential of modified peptides in addressing complex biological changes.
In summary, the citation "Peptides 2008 29 529-535 CW49" points to a specific and impactful study concerning a novel antimicrobial peptide. This research, situated within a broader landscape of peptide science in 2008 and beyond, showcases the multifaceted nature of peptides, from their roles in immunity and disease to their potential therapeutic and cosmetic applications. The ongoing investigation into peptide structures, functions, and modifications, including the development of peptide analogues and peptide antagonists, continues to drive innovation across numerous scientific disciplines. The study of MHC-I peptide loading and the synthesis of specific peptides further illustrate the depth and breadth of this dynamic field.
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
